Detalle Novedad

To give potential applicants as much time as possible to form consortia and prepare their proposals, IMI regularly publishes draft topic texts on this page several weeks before the official Call launch.

Draft topic texts are subject to consultations involving IMI's States Representatives Group, Scientific Committee, and the European Commission. They must also be approved by the IMI Governing Board. Depending on the results of the consultations and approval process, the final topic text may differ significantly from the draft versions initially published here, and some topics may not be included in a Call in the end.

The following topics are under consideration for inclusion in future IMI Calls for proposals:

• Targeted immune intervention for treatment of non-response and remission.


• Non-invasive clinical molecular imaging of immune cells.


• Development of a platform for federated and privacy-preserving machine learning in support of drug discovery.


• Centre of excellence – remote decentralised clinical trials.

More information in the next link:  IMI (Innovative Medicine Initiative) - new indicative Call topics published